New eye drop aims to ease dry eye symptoms and boost work productivity

NCT ID NCT07266948

Recruiting now Symptom relief Sponsor: Southern College of Optometry Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a drug called TRYPTYR (Acoltremon) can improve quality of life and work ability in adults with chronic dry eye disease. About 40 participants who are unhappy with their current treatment will use the eye drops for one month. Researchers will measure changes in quality-of-life scores and symptom relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Acoltremon (TRYPTYR)
What this could lead to: If it works, this could offer a new option for people with dry eye disease whose current treatment isn't helping enough, potentially improving daily comfort and work performance.
What could go wrong: This is a small, short-term study (40 people, 1 month) with no placebo group, so results may not be reliable or apply to everyone. The drug may not work better than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome eye disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE EYE DISEASES EYES DRY CHRONIC

Contacts and locations

Locations

Complete Eye Care of Medina
RECRUITING

Medina, Minnesota, 55340, United States
Kannar Eye Care
RECRUITING

Pittsburg, Kansas, 66762, United States
The Southern College of Optometry
RECRUITING

Memphis, Tennessee, 38104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.